sglt2 glp-1 news Use of Receptor Agonists and Inhibitors Among Patients with Type 1 Diabetes: A Nationwide Register-Based Cohort Study Increasing Prescribing of SGLT2is, GLP-1

DoseVita calculates your average severity score and displays it with a color-coded gauge green for mild, yellow for moderate, red for severe so you can spot patterns and share meaningful data with your doctor

Allergens None

This material is only intended for eligible counterparties and professional clients

For many, this path can feel overwhelming, especially with the emergence of highly effective medications like semaglutide

Sensitivity solution: Accurately measure 1 mL of the reference solution into a 10-mL volumetric flask

By Lauren Lund, APRN-CNP Reviewed by Laurianne Scott, DO Last Updated: 01/26/2025 In recent years, GLP-1 (glucagon-like peptide-1) medications have garnered significant attention for their effectiveness in helping individuals with weight loss